Number of resources: 23444

2012

Spencer JS, Duthie MS, Geluk A, Balagon MF, Kim HJ, Wheat WH, et al. Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy. Mem Inst Oswaldo Cruz. 2012;107 Suppl 1:79-89. Abstract
Larrea MR, Carreño MC, Fine PE. Patterns and trends of leprosy in Mexico: 1989-2009. Lepr Rev. 2012;83(2):184-94. Abstract
Samraj A, Kaki S, Rao PS. Help-seeking habits of untreated leprosy patients reporting to a referral hospital in Uttar Pradesh, India. Indian J Lepr. 2012;84(2):123-9. Abstract
Premkumar R. The eminent Indian leprosy researcher--Dr. C. K. Job. Indian J Dermatol Venereol Leprol. 2012;78(2):223-4. Abstract
Matsuoka M. [Collaboration between Korea and Japan for basic research on leprosy]. Nihon Hansenbyo Gakkai Zasshi. 2012;81(3):205-7. Abstract
Qu F, Wu C-, Hou J-, Jin Y, Zhang J-. Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide. PLoS ONE. 2012;7(12):e52454. Abstract
Fava V, Orlova M, Cobat A, Alcaïs A, Mira M, Schurr E. Genetics of leprosy reactions: an overview. Mem Inst Oswaldo Cruz. 2012;107 Suppl 1:132-42. Abstract
Talhari S, de Grossi MA, de Oliveira ML, Gontijo B, Talhari C, Penna GO. Hansen's disease: a vanishing disease? Mem Inst Oswaldo Cruz. 2012;107 Suppl 1:13-6. Abstract
Karamanou M, Kyriakis KP, Poulakou-Rebelakou E, Androutsos G. [Leprosy in Byzantium.]. La Presse Médicale. 2012.
Robertson H, Chamberlain MA, Rao PS. Letter to the editor : In response to ‘an overview of training and development needs’ (Ebenso, J. Leprosy Review. June 2012). Lepr Rev. 2012;83(4):394-5.
Natrajan M, Katoch K, Katoch VM, Das R, Sharma VD. Histological diagnosis of early and suspicious lleprosy by in situ PCR.. 2012;84:185-94. Abstract
Desikan KV. Elimination of leprosy & possibility of eradication - the Indian scenario. Indian J Med Res. 2012;135(1):3-5.
Feenstra SG, Nahar Q, Pahan D, Oskam L, Richardus J. Social contact patterns and leprosy disease: a case-control study in Bangladesh. Epidemiol Infect. 2012;141 (3):1-9. Abstract
Penna GO, Pontes AM, Cruz R, Gonçalves HS, Penna ML, Bührer-Sékula S. A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design. Mem Inst Oswaldo Cruz. 2012;107 (Suppl 1):22-7. Abstract
Taheri J-, Mortazavi H, Moshfeghi M, Bakhshi M, Bakhtiari S, Azari-Marhabi S, et al. Oro-facial manifestations of 100 leprosy patients. Med Oral Patol Oral Cir Bucal. 2012. Abstract
Düppre NC, Camacho LA, Sales AM, Illarramendi X, Nery JA, Sampaio EP, et al. Impact of PGL-I Seropositivity on the Protective Effect of BCG Vaccination among Leprosy Contacts: A Cohort Study. PLoS Negl Trop Dis. 2012;6(6):e1711. Abstract
Bhoopat L, Thamprasert K, Suriyanond V, Smith T, Scollard DM, Theetranont C. Evolution of in situ immune responses in clinical subgrounps of erythema nodosum leprosum reactions of leprosy: an Immunoperoixdase study using suction-induced skin blisters. Chiang Mai Medical Journal. 2012;27(4):330-41. Abstract
Nuño González A, López Estebaranz JL, Salamanca Santamaría J, Pinedo Moraleda F. [Annular skin lesions in a patient with neurological symptoms as the clue to the diagnosis of Hansen's disease.]. Med Clin (Barc). 2012. Abstract
Lockwood DN, Cunha MD. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally. Lepr Rev. 2012;83(3):241-4.
Gulati A, Kaushik R, Kaushal V. Cytological diagnosis of lepromatous leprosy: A report of two cases with review of literature. J Cytol. 2012;29(3):203-4. Abstract